Yunping Mu

Yunping Mu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZZZongmeng Zhang
Zongmeng Zhang
JDJinlin Du
Jinlin Du
QXQihua Xu
Qihua Xu
CXChaofeng Xing
Chaofeng Xing
YLYuyu Li
Yuyu Li
FLFanghong Li
Fanghong Li
Adiponectin is an adipocytokine with anti-inflammatory and anticancer properties. Our previous study has shown that blood adiponectin levels were inversely correlated to the risk of nasopharyngeal carcinoma (NPC), and that adiponectin could directly suppress the proliferation of NPC cells. However, the effect of adiponectin on NPC metastasis remains unknown. Here, we revealed in clinical studies that serum adiponectin level was inversely correlated with tumor stage, recurrence, and metastasis in NPC patients, and that low serum adiponectin level also correlates with poor metastasis-free survival. Coculture with recombinant adiponectin suppressed the migration and invasion of NPC cells as well as epithelial–mesenchymal transition (EMT). In addition, recombinant adiponectin dampened the activation of NF-κB and STAT3 signaling pathways induced by adipocyte-derived proinflammatory factors such as leptin, IL-6, and TNF-α. Pharmacological activation of adiponectin receptor through its specific agonist, AdipoRon, largely stalled the metastasis of NPC cells. Taken together, these findings demonstrated that adiponectin could not only regulate metabolism and inhibit cancer growth, but also suppress the metastasis of NPC. Pharmacological activation of adiponectin receptor may be a promising therapeutic strategy to stall NPC metastasis and extend patients’ survival.

5 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ZZZongmeng Zhang
Zongmeng Zhang
JDJinlin Du
Jinlin Du
QXQihua Xu
Qihua Xu
YLYuyu Li
Yuyu Li
SZSujin Zhou
Sujin Zhou
FLFanghong Li
Fanghong Li
NPC is a type of malignant tumor with a high risk of local invasion and early distant metastasis. Resistin is an inflammatory cytokine that is predominantly produced from the immunocytes in humans. Accumulating evidence has suggested a clinical association of circulating resistin with the risk of tumorigenesis and a relationship between blood resistin levels and the risk of cancer metastasis. In this study, we explored the blood levels and the role of resistin in NPC. High resistin levels in NPC patients were positively associated with lymph node metastasis, and resistin promoted the migration and invasion of NPC cells in vitro. These findings were also replicated in a mouse model of NPC tumor metastasis. We identified TLR4 as a functional receptor in mediating the pro-migratory effects of resistin in NPC cells. Furthermore, p38 MAPK and NF-κB were intracellular effectors that mediated resistin-induced EMT. Taken together, our results suggest that resistin promotes NPC metastasis by activating the TLR4/p38 MAPK/NF-κB signaling pathways.

9 March 2023 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
QXQihua Xu
Qihua Xu
ZZZongmeng Zhang
Zongmeng Zhang
MTMinyi Tang
Minyi Tang
CXChaofeng Xing
Chaofeng Xing
HCHansi Chen
Hansi Chen
YMYunping Mu
Yunping Mu

9 November 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZZZongmeng Zhang
Zongmeng Zhang
YLYueying Liu
Yueying Liu
WFWenbin Feng
Wenbin Feng
PMPing Mao
Ping Mao
JYJianqin Yang
Jianqin Yang
YMYunping Mu
Yunping Mu

3 December 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
ALAolu Liu
Aolu Liu
ZLZhuang Li
Zhuang Li
JZJingwen Zeng
Jingwen Zeng
YPYuerong Peng
Yuerong Peng
SWShuai Wang
Shuai Wang
FLFanghong Li
Fanghong Li

3 September 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
XCXiping Cui
Xiping Cui
QHQiyi He
Qiyi He
HYHuiyi Yang
Huiyi Yang
YCYingshan Chen
Yingshan Chen
DSDing Shen
Ding Shen
SZsuqing Zhao
suqing Zhao